Open Access
BIO Web Conf.
Volume 55, 2022
5th International Conference on Frontiers of Biological Sciences and Engineering (FBSE 2022)
Article Number 01009
Number of page(s) 4
Published online 21 November 2022
  • ALHENAWI, E., AL-SAYYED, R., HUDAIB, A. & MIRJALILI, S. 2021. Feature selection methods on gene expression microarray data for cancer classification: A systematic review. Comput Biol Med, 140, 105051. [Google Scholar]
  • ANDERSON, S. F., SCHLEGEL, B. P., NAKAJIMA, T., WOLPIN, E. S. & PARVIN, J. D. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nature genetics, 19, 254-256. [CrossRef] [PubMed] [Google Scholar]
  • AUTEXIER, C. L., NEAL 2006. The structure and function of telomerase reverse transcriptase. Annu. Rev. Biochem, 75, 493-517. [CrossRef] [PubMed] [Google Scholar]
  • BALMAIN, A. 2020. The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk. Nature Genetics, 52, 1139-1143. [CrossRef] [PubMed] [Google Scholar]
  • BHATTACHARYA, P. & PATEL, T. N. 2021. A study of deregulated MMR pathways and anticancer potential of curcuma derivatives using computational approach. Scientific reports, 11, 1-21. [CrossRef] [PubMed] [Google Scholar]
  • DI FIORE, R., D’ANNEO, A., TESORIERE, G. & VENTO, R. 2013. RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis. Journal of Cellular Physiology, 228, 1676-1687. [CrossRef] [PubMed] [Google Scholar]
  • FULDA, S. 2009. Tumor resistance to apoptosis. International journal of cancer, 124, 511-515. [CrossRef] [PubMed] [Google Scholar]
  • GOLIAS, C. H., CHARALABOPOULOS, A. & CHARALABOPOULOS, K. 2004. Cell proliferation and cell cycle control: a mini review. International Journal of Clinical Practice, 58, 1134-1141. [CrossRef] [PubMed] [Google Scholar]
  • HANAHAN, D. & WEINBERG, R. A. 2000. The hallmarks of cancer. Cell, 100, 57-70. [CrossRef] [PubMed] [Google Scholar]
  • IRMINGER-FINGER, I. 2007. Science of cancer and aging. Journal of clinical oncology, 25, 1844-1851. [CrossRef] [PubMed] [Google Scholar]
  • KELLAND, L. 2007. Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway. Clinical Cancer Research, 13, 4960-4963. [CrossRef] [PubMed] [Google Scholar]
  • KNIBERG, H. 2015. Scrum and XP from the Trenches, Lulu. com. [Google Scholar]
  • LEE, D.-H. & PFEIFER, G. P. 2008. Translesion synthesis of 7, 8-dihydro-8-oxo-2′-deoxyguanosine by DNA polymerase eta in vivo. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 641, 19-26. [CrossRef] [Google Scholar]
  • MACHERET, M. & HALAZONETIS, T. D. 2015. DNA replication stress as a hallmark of cancer. Annual review of pathology, 10, 425-48. [CrossRef] [PubMed] [Google Scholar]
  • MARTINCORENA, I. & CAMPBELL, P. J. 2015. Somatic mutation in cancer and normal cells. Science, 349, 1483-1489. [CrossRef] [PubMed] [Google Scholar]
  • MARTÍNEZ, P. & BLASCO, M. A. 2010. Role of shelterin in cancer and aging. Aging cell, 9, 653-666. [CrossRef] [PubMed] [Google Scholar]
  • MCMAHON, S. B. 2014. MYC and the control of apoptosis. Cold Spring Harbor perspectives in medicine, 4, a014407. [CrossRef] [PubMed] [Google Scholar]
  • MILHOLLAND, B., AUTON, A., SUH, Y. & VIJG, J. 2015. Age-related somatic mutations in the cancer genome. Oncotarget, 6, 24627. [CrossRef] [PubMed] [Google Scholar]
  • PETITJEAN, A., ACHATZ, M., BORRESENDALE, A., HAINAUT, P. & OLIVIER, M. 2007. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene, 26, 2157-2165. [CrossRef] [PubMed] [Google Scholar]
  • PONDER, B. A. J. 2001. Cancer genetics. Nature, 411, 336-341. [CrossRef] [PubMed] [Google Scholar]
  • SCHMUTZ, I. & DE LANGE, T. 2016. Shelterin. Current Biology, 26, R397-R399. [CrossRef] [PubMed] [Google Scholar]
  • SPORN, M. B. 1996. The war on cancer. Lancet (London, England), 347, 1377-1381. [CrossRef] [PubMed] [Google Scholar]
  • SUDHAKAR, A. 2009. History of Cancer, Ancient and Modern Treatment Methods. Journal of cancer science & therapy, 1 2, 1-4. [CrossRef] [Google Scholar]
  • VAROL, U., KUCUKZEYBEK, Y., ALACACIOGLU, A., SOMALI, I., ALTUN, Z., AKTAS, S. & OKTAY TARHAN, M. 2018. Brcagenes: brca 1 and brca 2. apoptosis, 13, 19. [Google Scholar]
  • VELOZO, C. & ALBUQUERQUE, D. 2019. Microcomputed tomography studies of the effectiveness of XP-endo shaper in root canal preparation: a review of the literature. The Scientific World Journal, 2019. [Google Scholar]
  • WANG, F., MAO, A., TANG, J., ZHANG, Q., YAN, J., WANG, Y., DI, C., GAN, L., SUN, C. & ZHANG, H. 2019. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells. J Cell Physiol, 234, 13182-13190. [CrossRef] [PubMed] [Google Scholar]
  • WISHART, D. S. 2015. Is cancer a genetic disease or a metabolic disease? EBioMedicine, 2, 478-479. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.